Condensed Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Net cash used in operating activities	$ (474,912)	$ (384,027)
Cash from investing activities:
Patent expenditures	(14,079)	(4,074)
Net cash used in investing activities	(14,079)	(4,074)
Cash from financing activities:
Proceeds from issuance of note payable related party	573,835	445,584
Payments on notes payable related party	(82,500)	(10,000)
Payments on notes payable		(70,000)
Proceeds from sale of convertible preferred stock		20,000
Purchase and cancellation of treasury stock	(500)
Net cash provided by financing activities	490,835	385,584
Net change in cash	1,844	(2,517)
Cash and cash equivalents at beginning of period	7,261	2,819
Cash and cash equivalents at end of period	9,105	302
Supplemental disclosure of cash flow information
Cash paid for interest	3,669	4,654
Cash paid for income taxes	0	0
Non-Cash Transactions
Common stock issued for convertible debt		74,091
Reclassification of derivative liability to permanent equity		17,035
Forgiveness of accrued salaries		278,259
Preferred Stock Issued For Notes Payable Related Party And Interest [Member]
Non-Cash Transactions
Preferred Stock Issued		110,300
Preferred Stock Issued For Accrued Dividends And Interest [Member]
Non-Cash Transactions
Preferred Stock Issued		$ 23,578